HADV (Health Advance) 3-Year EBITDA Growth Rate: 0.00% (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Health Advance 3-Year EBITDA Growth Rate?

Health Advance HADV -20.00% 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2017.

Health Advance's EBITDA per Share for the three months ended in Sep. 2017 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Health Advance  (OTCPK:HADV) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Health Advance 3-Year EBITDA Growth Rate Related Terms

HADV vs MYDP, HEWA, RXMD: 3-Year EBITDA Growth Rate Comparison

For the Pharmaceutical Retailers subindustry, Health Advance's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Health Advance 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Advance's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Health Advance's 3-Year EBITDA Growth Rate falls into.


Health Advance 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Health Advance (HADV) has a 3-Year EBITDA Growth Rate of 0.00% as of Sep. 2017. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Health Advance and its competitors.
Is Health Advance's 3-Year EBITDA Growth Rate too high?
Health Advance's current 3-Year EBITDA Growth Rate is 0.00%.
How does Health Advance's 3-Year EBITDA Growth Rate compare to MYDP and HEWA?
Health Advance's 3-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median 3-Year EBITDA Growth Rate is 10.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Health Advance and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Advance's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Advance stock overvalued right now?
Health Advance (HADV) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Health Advance (HADV), the current 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Health Advance Business Description

Address 9131 Keele Street, Suite A4, Vaughan, ON, CAN, L4K 0G7
Health Advance Inc is engaged in the retail domain. The Company is focused on products that are oriented to health and wellness. The first example of this is a proprietary CBD-infused wine beverage. The company is in the analysis stage for Immune boosting nutraceuticals, and human wellness products.